Letter to the editor: Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: A “social teratogen” or moderator of developmental risk

Authors

  • Gil Klinger,

    Corresponding author
    1. Neonatal Intensive Care Unit, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
    2. Beilinson Teratology Information Service, Rabin Medical Center, Petach Tikva, Israel
    3. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Neonatal Intensive Care Unit, Schneider Children's Medical Center of Israel, 14 Kaplan Street, Petach Tikva, Israel, 49202
    Search for more papers by this author
  • Paul Merlob

    1. Neonatal Intensive Care Unit, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel
    2. Beilinson Teratology Information Service, Rabin Medical Center, Petach Tikva, Israel
    3. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for more papers by this author

No abstract is available for this article.

Ancillary